Dr. Catherine Sherwin, was a Professor at the Department of Pediatrics, Wright State University Boonshoft School of Medicine and Dayton Children's Hospital. She earned her Ph.D. at the University of Otago, Dunedin School of Medicine, New Zealand in Paediatric Clinical Pharmacology in 2007. She then completed one year of Postdoctoral training in the Women’s and Children’s Health in Dunedin and then a two-year T32 Fellowship training program in the Divisions of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center. She received board certification from the American Board of Clinical Pharmacology in 2011. Dr. Sherwin has expertise and experience in the development of quantitative pharmacometric (PK/PD/PG) models in special populations, including pediatric and neonatal patients.
Dr. Sherwin’s areas of clinical research focus were clinical pharmacology/toxicology and pharmacometrics within the area of pediatrics and maternal health, and specifically the juncture of the two: neonatology and pregnancy. She was highly committed to understanding how the physical size and physiological based information can be systematically utilized to understand the inherent pharmacology. She had a combination of skill sets that are in high demand; having been trained in pediatric clinical pharmacology and pharmacometrics. The natural overlap between these two areas of expertise complement one another and allowed Dr. Sherwin to provide a unique level of technical depth and research insight to pediatric studies. Dr. Sherwin’s research hadba highly clinical focus and combines the utility and innovation of modeling and simulation to provide research answers to real clinical questions.